Metraipolis › archive › dc_ba1c34f6ffbc
Naringenin Enhances the Inhibitory Effect of Regorafenib on HepG2 Hepatocellular Carcinoma Cell Viability with Modulation of E-Cadherin and MRP1 Gene Expression — Europe PMC PMID:42942114
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42942114
- DOI
- 10.3390/ijms27209347
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T19:30:49.198Z
- SHA-256 of the archived text
69f25afec05e229012f595760b9ac74e2d0460831ce9ad9c625fc596154df2b6- Stable URL of this page
https://metraipolis.com/documento/dc_ba1c34f6ffbc
How to cite
Naringenin Enhances the Inhibitory Effect of Regorafenib on HepG2 Hepatocellular Carcinoma Cell Viability with Modulation of E-Cadherin and MRP1 Gene Expression — Europe PMC PMID:42942114 — Europe PMC (en), https://europepmc.org/article/MED/42942114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba1c34f6ffbc (Metraipolis archive dc_ba1c34f6ffbc, sha256 69f25afec05e229012f595760b9ac74e2d0460831ce9ad9c625fc596154df2b6)
BibTeX
@misc{dcba1c34f6ffbc,
title = {Naringenin Enhances the Inhibitory Effect of Regorafenib on HepG2 Hepatocellular Carcinoma Cell Viability with Modulation of E-Cadherin and MRP1 Gene Expression — Europe PMC PMID:42942114},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42942114},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba1c34f6ffbc; sha256 69f25afec05e229012f595760b9ac74e2d0460831ce9ad9c625fc596154df2b6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42942114. Agents can read the archived copy with the MCP tool read_document.